Heathbridge Capital Management Ltd. Reduces Holdings in Haleon plc (NYSE:HLN)

Heathbridge Capital Management Ltd. decreased its holdings in shares of Haleon plc (NYSE:HLN) by 1.4% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 1,109,300 shares of the company’s stock after selling 16,100 shares during the period. Haleon makes up approximately 4.2% of Heathbridge Capital Management Ltd.’s investment portfolio, making the stock its 11th largest holding. Heathbridge Capital Management Ltd.’s holdings in Haleon were worth $10,583,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of HLN. FMR LLC grew its stake in shares of Haleon by 5.8% during the third quarter. FMR LLC now owns 104,918,269 shares of the company’s stock worth $1,110,035,000 after acquiring an additional 5,768,117 shares during the last quarter. Wellington Management Group LLP boosted its position in Haleon by 49.9% in the third quarter. Wellington Management Group LLP now owns 9,152,490 shares of the company’s stock valued at $96,833,000 after buying an additional 3,046,841 shares during the last quarter. JPMorgan Chase & Co. boosted its position in Haleon by 25.3% in the third quarter. JPMorgan Chase & Co. now owns 5,084,202 shares of the company’s stock valued at $53,791,000 after buying an additional 1,026,939 shares during the last quarter. Natixis Advisors LLC boosted its position in Haleon by 142.5% in the third quarter. Natixis Advisors LLC now owns 1,473,767 shares of the company’s stock valued at $15,593,000 after buying an additional 866,070 shares during the last quarter. Finally, Van ECK Associates Corp boosted its position in Haleon by 13.5% in the fourth quarter. Van ECK Associates Corp now owns 3,509,400 shares of the company’s stock valued at $33,480,000 after buying an additional 418,609 shares during the last quarter. Hedge funds and other institutional investors own 6.67% of the company’s stock.

Haleon Trading Down 2.5 %

Shares of NYSE:HLN opened at $9.71 on Friday. Haleon plc has a 12-month low of $7.89 and a 12-month high of $10.80. The company has a market capitalization of $43.93 billion, a PE ratio of 28.54, a PEG ratio of 2.70 and a beta of 0.28. The business has a 50 day moving average of $9.54 and a two-hundred day moving average of $9.80. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44.

Analysts Set New Price Targets

A number of equities research analysts recently commented on HLN shares. Sanford C. Bernstein lowered Haleon from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 8th. Morgan Stanley lowered Haleon from an “overweight” rating to an “equal weight” rating in a research report on Friday, January 10th. Three investment analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Haleon presently has an average rating of “Moderate Buy” and a consensus price target of $10.95.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.